[Form 4] Vicarious Surgical Inc. Insider Trading Activity

Rhea-AI Filing Summary

Director Donald F. Tang reported open-market dispositions of Vicarious Surgical Inc. (RBOT) common stock. He sold 100 shares on 08/19/2025 at $6.68 and 2,059 shares on 08/20/2025 at $6.04, reducing his direct holdings from 45,237 shares to 43,178 shares. The form is signed by an attorney-in-fact and does not disclose any derivative transactions or additional context.

Positive

• None.

Negative

• Director sold shares: 100 shares on 08/19/2025 at $6.68 and 2,059 shares on 08/20/2025 at $6.04, reducing reported direct holdings from 45,237 to 43,178 shares.

Insights

Financial Analyst

TL;DR: Director sold a small block of shares over two days, reducing holdings by 2,059 shares to 43,178 total.

The filing records two open-market sales by a company director: 100 shares at $6.68 and 2,059 shares at $6.04. The transactions are non-derivative and executed on consecutive days, resulting in a reported direct holding of 43,178 shares. No information on intent, plan, or connection to company events is provided, and no derivative positions are shown.

Corporate Governance Expert

TL;DR: Routine insider sale disclosed; form shows compliance with Section 16 reporting but provides no governance context.

The Form 4 documents timely disclosure of insider sales by a director. The signature is provided by an attorney-in-fact. The filing does not indicate any Rule 10b5-1 plan or related agreements, nor does it show officer status or other changes in relationship. This appears to be a routine ownership update without further governance details.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tang Donald F

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/19/2025		S		100	D	$6.68	45,237	D
Class A Common Stock	08/20/2025		S		2,059	D	$6.04	43,178	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Erin Checka, Attorney-in-Fact	08/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Donald F. Tang report on the Form 4 for RBOT?

He reported two open-market sales: 100 shares on 08/19/2025 at $6.68 and 2,059 shares on 08/20/2025 at $6.04.

How many RBOT shares does the reporting person own after the reported transactions?

43,178 shares are reported as beneficially owned following the transactions.

Does the Form 4 show any derivative transactions or option activity for RBOT?

No. Table II for derivative securities contains no reported transactions; only non-derivative common stock sales are listed.

Was the Form 4 signed and dated?

Yes. The form is signed by an attorney-in-fact (/s/ Erin Checka) dated 08/21/2025.

Does the filing state whether the sales were part of a 10b5-1 plan?

No. The filing does not indicate that the transactions were made pursuant to a 10b5-1 plan.